Daiichi Sankyo seeks Japanese approval for Enhertu to treat patients with HER2 positive metastatic solid tumours: Tokyo Friday, April 25, 2025, 09:00 Hrs [IST] Daiichi Sankyo has ...

Guilt and shame – not hope for recovery – are among the most common reasons terminally ill cancer patients continue with minimally beneficial treatments at the end of life, according to Rutgers ...

Removing EPO signalling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

A new artificial intelligence (AI) tool could soon help general practitioners (GPs) detect lung cancer in patients up to four ...

AACR's achievement awards and lectureships recognize innovation in basic, translational, clinical, and epidemiological cancer research.

Initial tests have produced promising results, having shown that it is able to detect 12 of the most lethal and common ...

Cancer risk from a single CT scan is low, but repeated exposure could increase the risk of radiation-induced cancer.

BriaCell Therapeutics (TSX:BCT), a Canadian biotechnology stock developing cancer immunotherapies, announced the resolution ...

The threat of rising cancer cases in the future statewide has prompted the Medical University of South Carolina (MUSC) to ...

Key treatments for Alzheimer’s, rare cancers, and infectious diseases are under review, with new vaccines and therapies like ...

According to the American Cancer Society, smoking tobacco is responsible for around 20 percent of all cancer cases and 30 ...